Hong Kong Star Brand Award 2015

17 November 2015

We are pleased to announce that Eagle IP has won the Hong Kong Star Brand Award 2015 in the SME category from the Hong Kong Small and Medium Enterprises (SME) Association in recognition of our effort in building up our brand in providing quality IP service for anyone seeking IP advice in Hong Kong and aboard.

Our Past Events

Eagle IP Celebrates 20th Anniversary, Reflecting on Two Decades of Excellence

21 May 2025

Eagle IP is Coming Back to LSPN in Boston!

24 April 2025

AIPLA Women in IP Global Networking Event in Hong Kong

3 April 2025

Talk at Hong Kong Christian Service

31 October 2024

Talk for HKUST Entrepreneurship 101 Training Program

31 October 2024

IP Training Programme on patent commercialization and technology transfer

8 October 2024

Recommended Insights

Diagnostic Claims in China

9 January 2020

The Chinese Patent Law excludes patenting methods of diagnosing or treating a disease. More specifically, this refers to processes of identifying, determining, or eliminating the cause or focus of diseases which are practiced directly on living human or animal bodies. Please keep in mind that instruments used for implementing these methods are still patentable. So […]

How a Secondhand Ground Brush Wiped Away a Chinese Patent

4 December 2024

A Chinese robot vacuum company digs up “hidden evidence” to successfully invalidate a patent owned by its biggest competitor. Highlights Background With the growth of online shopping, it is easier than ever to provide evidence of a sale when the product is still being sold on the market. But what if the product is no […]

AI, Big Data, and Blockchain - CNIPA seeks public comment on draft patent examination guidelines

21 November 2019

Exciting new changes continue to happen with the Chinese Patent Office (CNIPA). On November 12, 2019, the CNIPA published a new set of amendments to Part II Chapter 9 of the Patent Examination Guidelines (“Draft”) and requested public comment by December 11, 2019. In summary, the new guidelines clarify how emerging technologies involving artificial intelligence, […]

China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux

24 May 2021

The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]